What is Henry Schein Inc.?
provides health care products and services to office-based dental and medical practitioners worldwide.
0L3C · Verdict
Moderate reward · elevated risk
0L3C has limited near-term tailwinds — profitability and balance sheet weigh on the model output.
Based on 88% data coverage
0L3C · Verdict
3% net margin · 9% ROE
Interest covered 4.6×
Rev +2.2% CAGR · earnings -1.5%
Below average
Model-based scoring. For information only — not financial advice.
provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The company is listed on the LSE in UK, and a P/E ratio of 0.2x.
The scoring profile indicates limited reward potential at this time, with momentum and size offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.